{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:52:23Z","timestamp":1783529543210,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI084390"],"award-info":[{"award-number":["R01AI084390"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12981-018-0208-9","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T05:33:12Z","timestamp":1543210392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-term virological outcome in children receiving first-line antiretroviral therapy"],"prefix":"10.1186","volume":"15","author":[{"given":"Padmapriyadarsini","family":"Chandrasekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Shet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramalingam","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. N.","family":"Sanjeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Subramanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suba","family":"Sunderesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karunaianantham","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elumalai","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navaneethan","family":"Poornagangadevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke E.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chockalingam","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"208_CR1","unstructured":"Global and Regional Trends\u2014UNICEF DATA: monitoring the situation of children and women. https:\/\/data.unicef.org\/topic\/hivaids\/global-regional-trends\/ . Accessed 23 June 2018."},{"key":"208_CR2","unstructured":"The Global HIV\/AIDS Epidemic. https:\/\/www.hiv.gov\/federal-response\/pepfar-global-aids\/global-hiv-aids-overview . Accessed 20 Oct 2018."},{"key":"208_CR3","unstructured":"World Health Organization. WHO early release guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV September 2015. Geneva: World Health Organization; 2015. http:\/\/www.who.int\/hiv\/pub\/guidelines\/en\/ . Accessed 28 June 2018."},{"key":"208_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2431-12-161","volume":"12","author":"DN Koye","year":"2012","unstructured":"Koye DN, Ayele TA, Zeleke BM. Predictors of mortality among children on antiretroviral therapy at a referral hospital, Northwest Ethiopia: a retrospective follow up study. BMC Pediatr. 2012;12:161.","journal-title":"BMC Pediatr"},{"issue":"7","key":"208_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.296.7.827","volume":"296","author":"SM Hammer","year":"2006","unstructured":"Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, et al. Treatment for adult HIV infection: 2006 recommendations of the international AIDS society-USA panel. JAMA. 2006;296(7):827\u201343.","journal-title":"JAMA"},{"key":"208_CR6","unstructured":"UNAIDS 90-90-90: treatment for all. http:\/\/www.unaids.org\/en\/resources\/909090 . Accessed 23 June 2018."},{"key":"208_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1742-6405-10-25","volume":"10","author":"R Sebunya","year":"2013","unstructured":"Sebunya R, Mussime V, Kitaka SB, Ndeezi G. Incidence and risk factors for first-line antiretroviral treatment failure among Ugandan children attending an urban HIV clinic. AIDS Res Ther. 2013;10:25.","journal-title":"AIDS Res Ther"},{"key":"208_CR8","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1001\/jama.2013.3710","volume":"309","author":"ED Lowenthal","year":"2013","unstructured":"Lowenthal ED, Ellenberg JH, Machine E, Sagdeo A, Boiditsew S, Steenhoff AP, et al. Association between African based compared with nevirapine-based antiretroviral regimens and virological failure in HIV infected children. JAMA. 2013;309:1803\u20139.","journal-title":"JAMA"},{"key":"208_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12879-016-1402-9","volume":"16","author":"O Kukoyi","year":"2016","unstructured":"Kukoyi O, Renner L, Powell J, Barry O, Prin M, Kusah J, et al. Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana. BMC Infect Dis. 2016;16:58.","journal-title":"BMC Infect Dis"},{"key":"208_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/INF.0b013e3181ed2af3","volume":"30","author":"RE Barth","year":"2011","unstructured":"Barth RE, Tempelman HA, Smelt E, Wensing AM, Hoepelman AI, Geelen SP. Long-term outcome of children receiving antiretroviral treatment in rural South Africa. Pediatr Infect Dis J. 2011;30:52\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"208_CR11","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1097\/QAD.0000000000000438","volume":"28","author":"T Duong","year":"2014","unstructured":"Duong T, Judd A, Collins IJ, Doerholt K, Lyall H, Foster C, et al. Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland. AIDS. 2014;28:2395\u2013405.","journal-title":"AIDS"},{"key":"208_CR12","unstructured":"National AIDS Control Organisation. National paediatric initiative on HIV-AIDS. http:\/\/www.naco.gov.in\/pressrelease\/national-paediatric-initiative-hiv-aids-launched . Accessed 28 June 2018."},{"issue":"3","key":"208_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/INF.0000000000001829","volume":"37","author":"C Padmapriyadarsini","year":"2018","unstructured":"Padmapriyadarsini C, Shet A, Srinivasan R, Ramachandran G, Sanjeeva GN, Devi P, et al. High prevalence of lipid abnormalities and insulin resistance among antiretroviral na\u00efve HIV-infected children in India. Pediatr Infect Dis J. 2018;37(3):253\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"208_CR14","unstructured":"WHO manual for HIV drug resistance testing using dried blood spot specimens, July 2012. http:\/\/www.who.int\/hiv\/pub\/drugresistance\/dried_blood_spots\/en\/ . Accessed 5 July 2016."},{"key":"208_CR15","unstructured":"WHO Global Database on Child Growth and Malnutrition. Compiled by Mercedes de Onis and Monika Bl\u00f6ssner Programme of Nutrition. Geneva:World Health Organisation; 1997. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/63750\/WHO_NUT_97.4.pdf;jsessionid=E8549D8861C7DC1EA9079BF6B8F98AD5?sequence=1 . Accessed 28 June 2018."},{"key":"208_CR16","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2013. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24716260 . Accessed 30 June 2018."},{"key":"208_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13104-016-2334-6","volume":"10","author":"DW Gunda","year":"2017","unstructured":"Gunda DW, Kidenya BR, Mshana SE, Kilonzo SB, Mpondo BCT. Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on first-line antiretroviral therapy in Mwanza, North-western Tanzania. BMC Res Notes. 2017;10:45.","journal-title":"BMC Res Notes"},{"issue":"9","key":"208_CR18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/INF.0b013e3181a458f9","volume":"28","author":"P Jittamala","year":"2009","unstructured":"Jittamala P, Puthanakit T, Chaiinseeard S, Sirisanthana V. Predictors of virologic failure and genotypic resistance mutation patterns in Thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Pediatr Infect Dis J. 2009;28(9):826\u201330.","journal-title":"Pediatr Infect Dis J"},{"key":"208_CR19","unstructured":"National Guidelines on Second-line and Alternative First-line ART for Adults and Adolescents. May 2013. National AIDS Control Organization. Ministry of Health and Family Welfare. Government of India. http:\/\/www.naco.gov.in\/sites\/default\/files\/National%20Guidelines%20on%20Secondline%20and%20Alternative%20Firstline%20ART%20For%20Adults%20and%20Adolescents%20May%202013_0.pdf . Accessed 1 July 2018."},{"key":"208_CR20","unstructured":"WHO. What\u2019s new in treatment monitoring: viral load and CD4 testing\u2014HIV treatment and care. July 2017. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255891\/WHO-HIV-2017.22-ng.pdf?sequence=1 . Accessed 20 Oct 2018."},{"key":"208_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1742-6405-8-40","volume":"8","author":"T Bunupuradah","year":"2011","unstructured":"Bunupuradah T, Puthanakit T, Kosalaraksa P, Kerr S, Boonrak P, Prasitsuebsai W, et al. Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV infected children. AIDS Res Ther. 2011;8:40.","journal-title":"AIDS Res Ther"},{"issue":"3","key":"208_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/QAI.0b013e318042d613","volume":"45","author":"DC Wamalwa","year":"2007","unstructured":"Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, Richardson BA, et al. Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic Syndr. 2007;45(3):311\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"208_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1177\/2325957414531621","volume":"13","author":"DR Joel","year":"2014","unstructured":"Joel DR, Mabikwa V, Makhanda J, Tolle MA, Anabwani GM, Ahmed SF. The prevalence and determinants of short stature in HIV-infected children. J Int Assoc Provid AIDS Care. 2014;13(6):529\u201333.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"1","key":"208_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1210\/jc.2003-031942","volume":"89","author":"S Arpadi","year":"2004","unstructured":"Arpadi S, Horlick M, Shane E. Metabolic bone disease in human immunodeficiency virus-infected children. J Clin Endocrinol Metab. 2004;89(1):21\u20133.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"208_CR25","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1086\/648079","volume":"49","author":"AL Ciaranello","year":"2009","unstructured":"Ciaranello AL, Chang Y, Margulis AV, Bernstein A, Bassett IV, Losina E, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009;49(12):1915\u201327.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"208_CR26","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1097\/INF.0000000000001575","volume":"36","author":"CS Crowell","year":"2017","unstructured":"Crowell CS, Maiga AI, Sylla M, Taiwo B, Kone N, Oron AP, et al. High rates of baseline drug resistance and virologic failure among ART-na\u00efve HIV infected children in Mali. Pediatr Infect Dis J. 2017;36(11):e258\u201363.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"208_CR27","doi-asserted-by":"publisher","first-page":"e0183080","DOI":"10.1371\/journal.pone.0183080","volume":"12","author":"BP Gopalan","year":"2017","unstructured":"Gopalan BP, Mehta K, D\u2019souza RR, Rajnala N, HK AK, Ramachandran G, et al. Sub-therapeutic nevirapine concentration during antiretroviral treatment initiation among children living with HIV: implications for therapeutic drug monitoring. PLoS ONE. 2017;12(8):e0183080. https:\/\/doi.org\/10.1371\/journal.pone.0183080 .","journal-title":"PLoS ONE"},{"issue":"9","key":"208_CR28","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1093\/jac\/dkx188","volume":"72","author":"C Kityo","year":"2017","unstructured":"Kityo C, Boerma RS, Sigaloff KCE, Kaudha E, Calis JCJ, Musiime V, et al. Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children. J Antimicrob Chemother. 2017;72(9):2587\u201395.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"208_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1742-6405-11-3","volume":"11","author":"S Pillay","year":"2014","unstructured":"Pillay S, Bland RM, Lessells RJ, Manasa J, de Oliveira T, Danaviah S. Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort. AIDS Res Ther. 2014;11(1):3.","journal-title":"AIDS Res Ther"},{"issue":"4","key":"208_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/QAI.0b013e3181cf4882","volume":"4","author":"SD Emmett","year":"2010","unstructured":"Emmett SD, Cunningham CK, Mmbaga BT, Kinabo GD, Schimana W, Swai ME, et al. Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. J Acquir Immune Defic Syndr. 2010;4(4):368\u201375.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"208_CR31","first-page":"956","volume":"136","author":"U Neogi","year":"2012","unstructured":"Neogi U, Gupta S, Rodrigues R, Sahoo PN, Rao SD, Rewari BB, et al. Dried blood spot HIV-1 RNA quantification: a useful tool for viral load monitoring among HIV-infected individuals in India. Indian J Med Res. 2012;136(6):956\u201362.","journal-title":"Indian J Med Res"},{"issue":"1","key":"208_CR32","doi-asserted-by":"publisher","first-page":"21362","DOI":"10.7448\/IAS.20.01.21362","volume":"20","author":"C Amani-Bosse","year":"2017","unstructured":"Amani-Bosse C, Dahourou DL, Malateste K, Amorissani-Folquet M, Coulibaly M, Cattes S, et al. Virological response and resistances over 12\u00a0months among HIV-infected children less than two years receiving first-line lopinavir\/ritonavir-based antiretroviral therapy in Cote d\u2019Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. J Int AIDS Soc. 2017;20(1):21362.","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"208_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/INF.0000000000001672","volume":"36","author":"AE Njom Nlend","year":"2017","unstructured":"Njom Nlend AE, Motaze AN, Ndiang ST, Fokam J. Predictors of virologic failure on first-line antiretroviral therapy among children in a referral pediatric center in Cameroon. Pediatr Infect Dis J. 2017;36(11):1067\u201372.","journal-title":"Pediatr Infect Dis J"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-018-0208-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12981-018-0208-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-018-0208-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T21:53:28Z","timestamp":1662501208000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-018-0208-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1186\/s12981-018-0208-9","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"14 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}